3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
7
Oropharyngeal Neoplasms
7
Lung Neoplasms
6
Carcinoma
6
Nasopharyngeal Carcinoma
4
Mouth Neoplasms
4
Laryngeal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Urinary Bladder Neoplasms
3
Mesothelioma, Malignant
3
Lymphoid Interstitial Pneumonia
3
Hypopharyngeal Neoplasms
3
Uterine Cervical Neoplasms
2
Pancreatic Neoplasms
2
Ganglioneuroblastoma
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Small Cell Lung Carcinoma
1
Sinonasal Squamous Cell Carcinoma
1
Salivary Gland Neoplasms
1
Resectable Intrahepatic Cholangiocarcinoma
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Osteosarcoma
1
Neuroblastoma
1
Mesothelioma
1
Interventions
Oxaliplatin
8
Fluorouracil
8
Nivolumab
7
Leucovorin
7
Paclitaxel
6
Capecitabine
5
Taxes
4
Specimen Handling
4
pembrolizumab
3
Trastuzumab
3
Ramucirumab
3
Magnetic Resonance Spectroscopy
3
Cisplatin
3
zimberelimab
2
zanidatamab
2
Radiotherapy
2
Folfox protocol
2
Carboplatin
2
zolbetuximab
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
tislelizumab
1
quemliclustat
1
obeticholic acid
1
futibatinib
1
dehydroftorafur
1
cixutumumab
1
balstilimab
1
Saline Solution
1
Radiofrequency Ablation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
Platinum
×
30 days
×
Clear all
No trials found.